NCT01595256
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Clinical trial condition
Gastrointestinal Neoplasms
Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.
9,331 public trials
2,090 recruiting studies
Gastrointestinal Neoplasms trial results
NCT02032485
- Conditions
- Abdominal Neoplasms, Colonic Diseases, Colorectal Cancer, +13 more
- Locations
-
- Institut Jules Bordet Brussels, Brussels Capital, Belgium
Completed
A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer
NCT01246960
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +10 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anchorage, Alaska, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alhambra, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bakersfield, California, United States
NCT00515931
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
- Locations
-
- Helsinki University Central Hospital Helsinki, Finland
Completed
A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)
NCT01286818
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Carcinoma, +11 more
- Locations
-
- ImClone Investigational Site Chiba, Japan
- ImClone Investigational Site Osaka, Japan
- ImClone Investigational Site Shizuoka, Japan
Completed
Population-Based Patient-Centric Care: Comprehensive Preventive Cancer Screening Using Health IT
NCT01372527
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +26 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
Completed
Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer
NCT00006389
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
- Locations
-
- University of Southern California Los Angeles, California, United States
NCT01751919
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +19 more
- Locations
-
- Kyungpook National University Daegu, South Korea
NCT00905918
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +11 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States